ht-va
Generic: glial cell line derived neurotrophic factor ("GDNF")
ht-va: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Hoth Therapeutics, Inc. (HOTH) | Preclinical |
Get deeper analysis on ht-va
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis